ARTICLE | Clinical News
Gammagard Liquid 10% regulatory update
July 4, 2011 7:00 AM UTC
EMA's CHMP issued a positive opinion to extend the indication for Baxter's Kiovig to include the treatment of multifocal motor neuropathy (MMN). Kiovig is approved in the EU for primary immunodeficien...